Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
87.5M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
75.2M
-
Shares change
-
+111K
-
Total reported value, excl. options
-
$685M
-
Value change
-
-$2.89M
-
Put/Call ratio
-
8.88
-
Number of buys
-
69
-
Number of sells
-
-56
-
Price
-
$9.12
Significant Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q3 2023
162 filings reported holding KURA - Kura Oncology, Inc. - Common Stock as of Q3 2023.
Kura Oncology, Inc. - Common Stock (KURA) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.2M shares
of 87.5M outstanding shares and own 85.89% of the company stock.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (7.34M shares), BlackRock Inc. (6.92M shares), BVF INC/IL (6.73M shares), EcoR1 Capital, LLC (5.81M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (4.37M shares), VANGUARD GROUP INC (3.92M shares), STATE STREET CORP (3.26M shares), Avoro Capital Advisors LLC (2.98M shares), Holocene Advisors, LP (2.44M shares), and ARMISTICE CAPITAL, LLC (2.24M shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.